Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine
Share
Biotech company Morphoceuticals has announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Seed funding will advance programs using electroceuticals in limb regeneration and amputation stump health.
